China Feihe Limited is a dairy company focused on the research, development, production, and sale of infant formula and full life-cycle nutrition products. The company operates in the infant formula, children's nutrition, and adult nutrition segments, with its core business centered on infant formula. Key brands include Star Fei Fan (Xing Fei Fan) and Feihe. The company maintains a vertically integrated supply chain, managing raw milk production and processing through its own farms and smart factories located in Harbin, Qiqihar, Kedong, Gannan, and Hengqin. It serves the Chinese market and has expanded into international markets through its facility in Canada. Notable partnerships include collaborations with Harvard Medical School's BIDMC and Peking University Health Science Center for brain development research, as well as roles as an official partner for the 9th Asian Winter Games and the Chang'e-5 lunar exploration program. The company's origins trace back to 1962 with the establishment of its predecessor, the Zhaoguang Farm Dairy Products Factory.

Summarised from the company's own disclosures, fiscal year ended Apr 2026

Industry Packaged Foods Homepage feihe.com
Sector Consumer Defensive IR page chinafeiheir.com/InvestorHome_cn
Tags
infant formula, dairy products, raw milk, nutritional products, milk protein, brain development, hmos, lactoferrin, smart manufacturing, Star Fei Fan, Feihe, Feihe HLJ, Feihe (Gannan) Dairy Products Co. Ltd., Vitamin World USA, YST, Zhaoguang Farm, Zhaoguang Dairy, Feihe-Harvard Medical School BIDMC Nutrition Laboratory
Press page —

Metrics

Valuation  
Market cap HK$ 25.49B
Market cap (USD) $ 3.248B
P/E 12.02
PEG —
P/BV 0.85
P/S 1.18
P/OCF 4.93
P/FCF —
Dividend yield 17.3%
Turnover / mcap 0.26%
Returns  
ROE 7.2%
ROI 7.3%
ROIC 7.3%
Profit margin 10.7%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -26.8%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 1.5%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 5.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Revenue 18.113B 20.749B 19.532B 21.311B 22.776B 18.592B 13.722B 10.392B
Net profit 1.939B 3.57B 3.39B 4.942B 6.871B 7.437B 3.935B 2.242B

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Share price — — — — 12.19 — — —
P/OCF — — — — 15.96 — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

CONNECTED TRANSACTION THE LOAN AGREEMENT Bull 1 Bear 0 Financing

Prompts

China Feihe Limited (ticker 6186), listed in Hong Kong.

ETFs Holding China Feihe Limited

ETF Weight in ETF Shares Market value As of
AVEE 0.17% 615,000 $ 219.728K Nov 16, 2026
AVES 0.07% 2,623,000 $ 937.15K Nov 16, 2026
AVEM 0.04% 33,119,000 $ 11.833M Nov 16, 2026
DFEV 0.03% 1,695,000 $ 596.355K Nov 12, 2026
MEMA 0.01% 4,000 $ 1,431.25 Aug 31, 2026
DFAX 0.00% 441,000 $ 155.158K Nov 12, 2026
DFEM 0.00% 259,000 $ 91.125K Nov 12, 2026